🇺🇸 FDA
Patent

US 12371499

Method of treating cancer using anti-AV8 antibodies

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 12371499 (Method of treating cancer using anti-AV8 antibodies) held by The Regents of the University of California expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/3955